Call for Abstract

Period for Abstract Submission

From September 1 at noon (JST) to October 28, 2022 at noon (JST)

Guideline for Abstract Submission

Presentation Type:

  • The program committee will decide whether to accept papers and the appropriate presentation type. There are two presentation types; Oral presentation and monitor presentation.
    The oral presentation is a general presentation. The presenter has 7 minutes to talk and 3 minutes for discussion.
    The monitor presentation is a presentation using your electric poster. The presenter stands beside the monitor on which his/her electric poster (CyPos) appears and discusses the research with interested attendees in the monitor presentation session. The monitor presentation session is for 30 minutes.
  • The room, date, and time for oral presentation will be notified in the email of acceptance.
  • We encourage you to take full advantage of visual aids through the use of computer monitor projection.

Note:

  • The JSRT program committee will decide whether to accept your presentation based on your abstract (max. 320 words), which must be submitted by Oct 28, 2022. All decisions are final.

  • Withdrawal after January 23, 2023 or no-show to the conference in Yokohama is subject to penalty of acceptance for future meetings and may not be published in the proceedings and the meeting program of the 79th annual meeting of the JSRT and the 2nd International Conference on Radiological Physics and Technology (ICRPT).

Submission Details

  • If the research to be presented is supported or funded (regardless of the amount of money) by industry, or research collaborators include employee(s) of a company related to the subject of the presentation, this fact must be disclosed.

  • Please disclose conflicts of interest within your PowerPoint and CyPos presentation materials.

  • In the case you are the presenting author on an accepted abstract and you cannot attend the conference, instead of withdrawing, please select a co-author to present the abstract in your place. You must choose at least one substitute presenter for you.
  • Please note that all speakers are generally deliver their presentation on-site.
    If you are unable to participate on-site, you will be required to deliver your presentation via Zoom.
    Kindly note that you may be asked to provide documents as evidences of travel ban or restrictions.

Presenting Author
Name

  • The author’s name should be written completely, avoiding any abbreviation.
  • First name and middle initial followed by last name.

Membership No.

  • Please enter your 7-digit membership number.
  • Non-members (Including Supporting members), Now applying for membership
    Please leave the text box blank.

Institution/Affiliation

  • The institution and affiliation of the presenting author should be written completely, avoiding any abbreviation.
    (ex.) The Third Department of Internal Medicine, University of Tokyo, Japan

Address

  • The presenting author’s address should be written completely, avoiding any abbreviation.
  • Country, Address, Postal/Zip Code, Telephone Number, Extension (if any).
  • Email address
    • Please make sure to use the e-mail address you have registered in the membership system “RacNe” (e-mail addresses of others, co-authors, academic advisors, etc. are prohibited).

    • Please note that due to system restrictions, the following e-mail domains are not accepted:
       ・@hanmail.net
       ・daum.net
  • A confirmation email will be sent to the registered email address automatically when you complete submission.
  • If you haven’t received a confirmation email within 24h, please first check your Spam/Bulk/Junk folder.
  • If you find an email in the “Spam” folder, please remember to mark it as “Not Spam” so that it will be delivered to your main inbox next time.
  • In case you haven’t received an email from the UMIN system, you are requested to log on to the confirmation/revision page to confirm your abstract submission.
  • If you have any questions, please contact us: icrpt@info.email.ne.jp

Co-author(s)

Please add a co-author if necessary (10 or less).

Alternative Presenter

  • In the case the registered presenter is unable to attend the meeting, one of the co-author(s) is required to be a presenter instead.
  • Please select at least one co-author as the alternative presenter.
  • Withdrawal after January 23, 2023 or no-show to the conference in Yokohama is subject to penalty of acceptance for future meetings and may not be published in the proceedings and the meeting program of the 79th annual meeting of the JSRT and the 2nd International Conference on Radiological Physics and Technology (ICRPT).

Research Category

  • Please select a group for your paper. The information is used for an effective and appropriate review process.

Title of Abstract

  • Please limit your title to 30 words or less.
  • Please describe the title in “Sentence Case”.
    (ex.) Molecular mechanism of cardiac hypertrophy induced by hypertension
  • Do NOT include company name(s), brand name(s), and specific name(s) particularly related to a company.
  • You are NOT supposed to list your titles as a series, such as 1st report, 2nd report.
  • Avoid using abbreviations except “Examples of abbreviations acceptable for the paper title”

Examples of abbreviations acceptable for the paper title

Abstract Body and A Novelty of Research Statement

  • Enter at least 3 of your research keywords (up to 5).

  • Type your abstract in the box. We recommend that you write your abstract using word processing software (e.g., MS-word, etc.) then paste it into the box.

  • The abstract is limited to 320 words, and should be constructed using the following section heads: [Purpose] [Methods] [Results] [Conclusion].

  • A Novelty of research statement, not exceeding 200 words, is also required for the review process.
  • The novelty statement will be used only in the review process, and will not be shown in the proceedings. Please do not use abbreviations without spelling out words in full on first occurrence.
  • You do not need to include an ethical research statement in the abstract, because it will be asked about in the following steps.

A Novelty of Research Statement

  • A Novelty of Research Statement is limited to 200 words.
  • Do NOT enter the title in the novelty of research statement.
  • Do NOT put your name and affiliation in the novelty of research statement.
  • Do NOT use abbreviations without spelling out words in full on first occurrence.

Questionnaire about research ethics

Research presenters shall comply with the basic principles of the following ethical considerations.

  • Considerations given to the protection of human rights
  • Considerations given to the respect for personal dignity and free will
  • Protection of personal information
  • Considerations given to research contents and appropriateness and rationality of procedures
  • Considerations given to disadvantages and dangers due to the implementation of research
  • Considerations given to animal protection

Research involving human participants, their data (including clinical images and clinical data) or biological materials must be approved/exempted by an appropriate institutional and/or national research ethics committee (including the name of the ethics committee).
The research must be conducted in accordance with the Helsinki Declaration of 1964 and any subsequent amendments or equivalent ethical standards.

The research presenter must certify that it was conducted in accordance with established ethical standards.

Applicable Research that does not have appropriate ethical approval cannot be submitted.

Please comply with the Guidance for “Ethical Guidelines for Life Science and Medical Research for Humans” (Partially revised on June 6, 2022)“
(https://www.mhlw.go.jp/content/000946358.pdf).

Duplicate submission

Duplicate submissions are generally not accepted. It is rarely permitted unless the research contains valuable information.

Conflict of Interest

If the research to be presented is:

  1. Supported or funded by corporates. (Regardless of the amount)
  2. Your research collaborator is an employee from a corporate related to the research.

The above fact(s) must be disclosed.

Regulations on withdrawal of abstract

  • It is the responsibility of the corresponding first author to complete his/her own presentation.
  • Any first author who cannot complete a presentation due to unavoidable reasons must inform the secretariat in advance.
  • The co-author should respond instead of the presenters.
  • If not, JSRT and ICRPT will not accept your application for presentation at the Congress for one year.

Password

  • Create your View/Update Password.
  • You need this password to view or edit your abstract.

Notification of Abstract Acceptance

  • A confirmation email will be sent to the registered email address automatically when you complete submission.
  • All abstracts submitted for the 2nd ICRPT are subject to peer review within the program committee after the abstract submission deadline.
  • The Committee’s decision will be sent to you by email.

Important Dates

  • September 1– October 28, 2022
  • December, 2022
  • Late December 2022
  • Mid-January 2023
  • February 2023
Abstract Submission
Access to Hotel Accommodation Site Opens
Notification of Paper Abstract Acceptance
Notification of presentation date and time
Electronic poster (CyPos) Submission

The abstract submission has been finished. Thank you for submitting many abstracts.

[Questions about ethic & Conflict of Interest]

If you chose “1.No” for “Did your research require ethical approval?”, please select “3.Others (please explain briefly in the box below.)” to the question “Did you conduct your research in accordance with the research design that had been approved by the IRB?”.
Then type “IRB not required” in the below box.

Contact (Online Registration Inquires)

For any further information about abstract submissions, please contact us by email.

Email: icrpt@info.email.ne.jp